相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients
N. Kamar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients
U. Allen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction
H. Omar et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients
Shellee A. Grim et al.
CLINICAL TRANSPLANTATION (2007)
Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab
J Svoboda et al.
TRANSPLANT INTERNATIONAL (2006)
A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder
A Humar et al.
TRANSPLANTATION (2006)
Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation
AL Taylor et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients
TC Lee et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Lymphomas after solid organ transplantation:: A collaborative transplant study report
G Opelz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Case report:: Kinetics of Epstein-Barr virus load in a bone marrow transplant patient with no sign of lymphoproliferative disease
MA Biasolo et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation
JWJ van Esser et al.
BLOOD (2002)
Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: Analysis of prognostic variables and long-term follow-up of 42 adult patients
DE Tsai et al.
TRANSPLANTATION (2001)
Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients
SJC Stevens et al.
BLOOD (2001)
分享论文
